⌘K

Home/Filings/4/0001104659-25-038036

4//SEC Filing

Ali Asif 4

Accession 0001104659-25-038036

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 4:30 PM ET

Size

5.0 KB

Accession

0001104659-25-038036

Insider Transaction Report

Form 4

Period: 2025-04-22

Protagonist Therapeutics, IncPTGX

Chief Financial Officer

Transactions

Sale
Common Stock
2025-04-22$46.00/sh−1,756$80,776→ 61,065 total

Footnotes (1)

[F1]Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

Documents

1 file

4
tm2513020-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001921163

Filing Metadata

Form type: 4
Filed: Apr 22, 8:00 PM ET
Accepted: Apr 23, 4:30 PM ET
Size: 5.0 KB

View on SEC.gov